Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cosopt Switch in Glaucoma Patients Uncontrolled on Latanoprost
NCT00273442Phase 4Completed
- Sponsor
- PRN Pharmaceutical Research Network
- Start
- Nov 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of dorzolamide in open-angle glaucoma (OAG), ocular hypertension, exfoliation syndrome (XFS) and 1 more, sponsored by PRN Pharmaceutical Research Network. Primary endpoint: Intraocular Pressure at 12 weeks. Started Nov 2005; status: completed.
02
Drugs
dorzolamide
03
Conditions
open-angle glaucoma (OAG)ocular hypertensionexfoliation syndrome (XFS)pigmentary glaucoma (PG)
Beyond the preview
Go deeper on NCT00273442.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00273442.